Business Description
AVITA Medical Inc
NAICS : 339112
SIC : 5047
ISIN : AU000000AVH4
Share Class Description:
FRA:51KB: ADRTotal Employee Number:
226Description
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | -0.45 | |||||
Debt-to-Equity | -2.08 | |||||
Debt-to-EBITDA | -1.28 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -12.39 | |||||
Beneish M-Score | -3.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.1 | |||||
3-Year EBITDA Growth Rate | -12.4 | |||||
3-Year EPS without NRI Growth Rate | -17.6 | |||||
3-Year FCF Growth Rate | -14.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 53.94 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 19.74 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.24 | |||||
9-Day RSI | 36.87 | |||||
14-Day RSI | 39.86 | |||||
3-1 Month Momentum % | 16.03 | |||||
6-1 Month Momentum % | 29.29 | |||||
12-1 Month Momentum % | -44.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.47 | |||||
Quick Ratio | 0.38 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 196.07 | |||||
Days Sales Outstanding | 51.84 | |||||
Days Payable | 217.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.6 | |||||
Shareholder Yield % | -0.57 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.36 | |||||
Operating Margin % | -54.62 | |||||
Net Margin % | -62.67 | |||||
EBITDA Margin % | -52.11 | |||||
FCF Margin % | -44.99 | |||||
OCF Margin % | -42.88 | |||||
ROA % | -75.73 | |||||
ROIC % | -64.68 | |||||
3-Year ROIIC % | -27.36 | |||||
ROC (Joel Greenblatt) % | -326.51 | |||||
ROCE % | -887.7 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.57 | |||||
EV-to-EBIT | -3.87 | |||||
EV-to-EBITDA | -4.12 | |||||
EV-to-Revenue | 2.15 | |||||
EV-to-Forward-Revenue | 1.54 | |||||
EV-to-FCF | -4.78 | |||||
Price-to-GF-Value | 0.37 | |||||
Earnings Yield (Greenblatt) % | -25.84 | |||||
FCF Yield % | -26.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AVITA Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 62.2 | ||
| EPS (TTM) (€) | -0.27 | ||
| Beta | 2.7659 | ||
| 3-Year Sharpe Ratio | -0.09 | ||
| 3-Year Sortino Ratio | -0.12 | ||
| Volatility % | 70.46 | ||
| 14-Day RSI | 39.86 | ||
| 14-Day ATR (€) | 0.018245 | ||
| 20-Day SMA (€) | 0.6449 | ||
| 12-1 Month Momentum % | -44.52 | ||
| 52-Week Range (€) | 0.524 - 1.305 | ||
| Shares Outstanding (Mil) | 153.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AVITA Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AVITA Medical Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 13:30 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 134 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 13:30 | In 44 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 43 days | ||
| General meeting for 2026 | 2026-06-03 15:00 | 0.67 (+0.00%) | ||
| investor webinar briefing and presentation | 2026-05-20 16:00 | 0.72 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 13:30 | 0.72 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.72 (+0.00%) | ||
| TD Cowen 46th Annual Health Care Conference | 2026-03-04 11:10 | 0.84 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 13:30 | 0.63 (+0.00%) |
Show
Entries
AVITA Medical Inc Frequently Asked Questions
What is AVITA Medical Inc(FRA:51KB)'s stock price today?
The current price of FRA:51KB is €0.61. The 52 week high of FRA:51KB is €1.31 and 52 week low is €0.52.
When is next earnings date of AVITA Medical Inc(FRA:51KB)?
The next earnings date of AVITA Medical Inc(FRA:51KB) is 2026-08-07 Est..
Does AVITA Medical Inc(FRA:51KB) pay dividends? If so, how much?
AVITA Medical Inc(FRA:51KB) does not pay dividend.
Press Release
Articles on AVITA Medical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers